naturalX Health Ventures is the €100mio VC arm of Schwabe Group for its investments in innovative, young companies as well as relevant VC funds.
We are flexible and can invest from seed to late stage. Our focus lies on Series A and Series B investments, where strong signs of product-market fit can be shown.
We invest into consumer healthcare and are particularly excited about mental health as well as proactive health, including sleep, nootropics, nutrition, prevention & longevity, bio-hacking, consumer diagnostics and more. We do not invest into biotech or medtech at this stage.
Schwabe Group, our parent company, is a global leader in plant-based pharmaceuticals with about €950 million in revenue mainly across Europe and North America.
The aim of investing is to combine the growth potential of young, innovative companies with the financial strength and access to different expertise of our parent company. We are a strategic-financial investor.